{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:21:34Z","timestamp":1771654894615,"version":"3.50.1"},"reference-count":19,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,3,17]],"date-time":"2006-03-17T00:00:00Z","timestamp":1142553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2006,6]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Hepatosplenic <jats:italic>\u03b3<\/jats:italic>\u2013<jats:italic>\u03b4<\/jats:italic> T\u2010cell lymphoma is a rare, usually fatal lymphoma and available literature on management is sparse. Allografting is probably the only curative option. We describe a further case with a dramatic, though transient response to Fludarabine and Alemtuzumab combination, following a failure of conventional chemotherapy. Given the dreadful prognosis with conventional chemotherapy, it is a regimen worth pursuing as a disease reduction strategy prior to allograft where appropriate.<\/jats:p>","DOI":"10.1111\/j.1600-0609.2006.00646.x","type":"journal-article","created":{"date-parts":[[2006,3,17]],"date-time":"2006-03-17T16:01:32Z","timestamp":1142611292000},"page":"531-534","source":"Crossref","is-referenced-by-count":59,"title":["A case of hepatosplenic <i>\u03b3<\/i>\u2013<i>\u03b4<\/i> T\u2010cell lymphoma with a transient response to Fludarabine and Alemtuzumab"],"prefix":"10.1111","volume":"76","author":[{"given":"S.","family":"Mittal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. J.","family":"Milner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. W.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. J.","family":"Culligan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,3,17]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1675"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/1042819021000035662"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199909058439"},{"key":"e_1_2_4_5_2","first-page":"215","article-title":"Hepatosplenic gamma delta T\u2010cell lymphoma associated with hepatitis B virus infection","volume":"44","author":"Ozaki S","year":"1998","journal-title":"J Med Invest"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2000.00804.x"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870120302"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428190109099342"},{"key":"e_1_2_4_9_2","first-page":"519","article-title":"Hepatosplenic gamma delta T\u2010cell lymphoma with leukemic phase successfully treated with 2\u2010chlorodeoxyadenosine","volume":"32","author":"Gopcsa L","year":"2002","journal-title":"Haematologia (Budap)"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03537_3.x"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10466"},{"key":"e_1_2_4_12_2","first-page":"E25","article-title":"Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma","volume":"86","author":"Ooi J","year":"2001","journal-title":"Haematologica"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V75.11.2213.2213"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401784"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf293"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i24.3729"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2004.19.391"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190310001609924"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000068493"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000050305"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2006.00646.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.2006.00646.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T03:09:11Z","timestamp":1696993751000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2006.00646.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,17]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["10.1111\/j.1600-0609.2006.00646.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2006.00646.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,17]]}}}